Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 19 minutes agoCompleted acquisition of Trawsfynydd and concurrent $14 million Capital Raise Excellent pipeline progress, led by candidates for COVID 19, influenza, and oncology programs Poised to initiate ...
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic...
WFRV 5 Green Bay· 3 hours agoIonis Pharmaceuticals, Inc. (Nasdaq: IONS) and Biogen Inc. (Nasdaq: BIIB) announced the decision to terminate development of BIIB105 (ION541) an investigational antisense oligonucleotide (ASO ...
Q1 2024 Panbela Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoI will start by discussing our clinical development program, recent achievements, and upcoming milestones. Then Sue will review our financial results before we open up the call for Q&A. Let ...
Bitcoin encounters $60k resistance amid market uncertainty
CryptoNewsZ.com· 24 hours agoBitcoin’s consolidation phase is not a new phenomenon. If anything, it is giving the market a sense...
Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com
Investing.com· 16 hours agoLumos Pharma (NASDAQ:LUMO), a biopharmaceutical company, detailed their progression towards a Phase...
Q3 2024 Palatin Technologies Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 hours agoAll coming from our highly productive research activities. Now for our PL9643 dry eye disease program, we reported the positive Phase 3 MELODY-1 results earlier in the quarter ...
Earnings call: Omeros Corporation reports Q1 2024 financial results By Investing.com
Investing.com· 2 hours agoOmeros (NASDAQ:OMER) Corporation (ticker: OMER), a biopharmaceutical company, reported a net loss of...
Pulsar Helium Announces Well Works at the Jetstream #1, Topaz Project
Digital Journal· 4 hours agoWell activities are expected to occur in three phases of work activities over approximately two weeks. The initial phase will focus on additional downhole data acquisitions ...
Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...
GuruFocus.com via Yahoo Finance· 7 hours agoPositive Points Ibezapolstat showed superior efficacy in eradicating C. difficile compared to vancomycin in Phase IIb trials, with a 94% success rate versus 71% for vancomycin ...
Q1 2024 ICAD Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 hours agoThese forward-looking statements are based on current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these ...
